{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:27:59Z","timestamp":1775737679348,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lungcancerjournal.info","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.lungcan.2015.08.012","type":"journal-article","created":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T15:31:19Z","timestamp":1440257479000},"page":"433-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Response evaluation in mesothelioma: Beyond RECIST"],"prefix":"10.1016","volume":"90","author":[{"given":"Lin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Tunariu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Blackledge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin O.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Popat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dow-Mu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.lungcan.2015.08.012_bib0005","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0010","doi-asserted-by":"crossref","first-page":"W125","DOI":"10.2214\/AJR.09.3519","article-title":"Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes","volume":"195","author":"Gill","year":"2010","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.lungcan.2015.08.012_bib0015","series-title":"In: Functional Imaging in Oncology","article-title":"Functional imaging of malignant pleural mesothelioma and other pleural and chest wall lesions","author":"Broncano","year":"2014"},{"key":"10.1016\/j.lungcan.2015.08.012_bib0020","unstructured":"CRUK. Mesothelioma incidence statistics. 2014; Available from: http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/types\/Mesothelioma\/incidence\/incidence - source1."},{"issue":"6","key":"10.1016\/j.lungcan.2015.08.012_bib0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ctrv.2012.12.005","article-title":"Malignant mesothelioma: new insights into a rare disease","volume":"39","author":"Remon","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2015.08.012_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"12","key":"10.1016\/j.lungcan.2015.08.012_bib0035","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2015.08.012_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0169-5002(98)00083-X","article-title":"The clinical importance of magnetic resonance imaging versus computed tomography in malignant pleural mesothelioma","volume":"22","author":"Knuuttila","year":"1998","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2015.08.012_bib0045","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/WNL.54.8.1557","article-title":"Comparison of diffusion-weighted MRI and CT in acute stroke","volume":"54","author":"Lansberg","year":"2000","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.lungcan.2015.08.012_bib0050","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00330-008-0918-9","article-title":"Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT","volume":"18","author":"Plathow","year":"2008","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0720-048X(00)00168-6","article-title":"Malignant pleural disease","volume":"34","author":"Bonomo","year":"2000","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.lungcan.2015.08.012_bib0060","series-title":"In: Seminars in Roentgenology","article-title":"Malignant pleural mesothelioma: role of CT, MRI, and PET\/CT in staging evaluation and treatment considerations","author":"Truong","year":"2013"},{"key":"10.1016\/j.lungcan.2015.08.012_bib0065","unstructured":"L. Cardinale, et al., Diagnostic imaging and workup of malignant pleural mesothelioma."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.mric.2008.03.004","article-title":"MR imaging of benign and malignant pleural disease","volume":"16","author":"Gill","year":"2008","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"issue":"12","key":"10.1016\/j.lungcan.2015.08.012_bib0075","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.crad.2005.05.015","article-title":"Use of imaging in the management of malignant pleural mesothelioma","volume":"60","author":"Benamore","year":"2005","journal-title":"Clin. Radiol."},{"issue":"3","key":"10.1016\/j.lungcan.2015.08.012_bib0080","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1378\/chest.118.3.604","article-title":"MRI and CT in the differential diagnosis of pleural disease","volume":"118","author":"Hierholzer","year":"2000","journal-title":"CHEST J."},{"issue":"4","key":"10.1016\/j.lungcan.2015.08.012_bib0085","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2214\/ajr.172.4.10587144","article-title":"Staging of malignant pleural mesothelioma: comparison of CT and MR imaging","volume":"172","author":"Heelan","year":"1999","journal-title":"Am. J. Roentgenol."},{"issue":"5","key":"10.1016\/j.lungcan.2015.08.012_bib0090","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2214\/ajr.159.5.1414807","article-title":"Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability","volume":"159","author":"Patz","year":"1992","journal-title":"Am. J. Roentgenol."},{"issue":"6","key":"10.1016\/j.lungcan.2015.08.012_bib0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1010-7940(03)00609-2","article-title":"Is there a role for pre-operative contrast-enhanced magnetic resonance imaging for radical surgery in malignant pleural mesothelioma?","volume":"24","author":"Stewart","year":"2003","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"1","key":"10.1016\/j.lungcan.2015.08.012_bib0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2015.08.012_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mpo.1154","article-title":"Response evaluation criteria in solid tumors (RECIST): new guidelines","volume":"37","author":"Tsuchida","year":"2001","journal-title":"Med. Pediatr. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1. 1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2005.12.013","article-title":"Modeling of mesothelioma growth demonstrates weaknesses of current response criteria","volume":"52","author":"Oxnard","year":"2006","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2015.08.012_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-5002(03)00292-7","article-title":"Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma","volume":"43","author":"van Klaveren","year":"2004","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2015.08.012_bib0125","doi-asserted-by":"crossref","first-page":"81916","DOI":"10.1118\/1.4810940","article-title":"Variability of tumor area measurements for response assessment in malignant pleural mesothelioma","volume":"40","author":"Labby","year":"2013","journal-title":"Med. Phys."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2015.08.012_bib0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/JTO.0b013e318208c83d","article-title":"A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteria","volume":"6","author":"Tsao","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2015.08.012_bib0140","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/JTO.0b013e3182370e69","article-title":"A practical guide to measure \u201call\u201d malignant pleural mesothelioma tumors by modified RECIST criteria?","volume":"6","author":"Nackaerts","year":"2011","journal-title":"J. Thorac. Oncol ."},{"issue":"8","key":"10.1016\/j.lungcan.2015.08.012_bib0145","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/JTO.0000000000000211","article-title":"Observer variability in mesothelioma tumor thickness measurements: defining minimally measurable lesions","volume":"9","author":"Armato","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2015.08.012_bib0150","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00330-008-0918-9","article-title":"Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT","volume":"18","author":"Plathow","year":"2008","journal-title":"Eur. Radiol."},{"issue":"16","key":"10.1016\/j.lungcan.2015.08.012_bib0155","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.ejca.2012.05.018","article-title":"Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma","volume":"48","author":"Blayney","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2015.08.012_bib0160","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JTO.0b013e3181d86ea9","article-title":"Chemotherapy induced pathologic complete response in malignant pleural mesothelioma: a review and case report","volume":"5","author":"Bech","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2015.08.012_bib0165","first-page":"254","article-title":"A pathological complete response after preoperative chemotherapy with carboplatin and pemetrexed in malignant pleural mesothelioma: a case report","volume":"2","author":"Pasello","year":"2010","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.lungcan.2015.08.012_bib0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejrad.2009.02.002","article-title":"Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma","volume":"74","author":"Ak","year":"2010","journal-title":"Eur. J. Radiol."},{"issue":"9","key":"10.1016\/j.lungcan.2015.08.012_bib0175","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","article-title":"Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans","volume":"48","author":"Francis","year":"2007","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2015.08.012_bib0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1183\/09031936.00146110","article-title":"Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?","volume":"38","author":"Frauenfelder","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.lungcan.2015.08.012_bib0185","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/annonc\/mds535","article-title":"Disease volumes as a marker for patient response in malignant pleural mesothelioma","volume":"24","author":"Labby","year":"2013","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2015.08.012_bib0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/JTO.0b013e31828354c8","article-title":"Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma","volume":"8","author":"Labby","year":"2013","journal-title":"J. Thorac. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/108497804323071913","article-title":"Role of 18F-FDG PET for evaluating malignant pleural mesothelioma","volume":"19","author":"Nanni","year":"2004","journal-title":"Cancer Biother. Radiopharm."},{"issue":"4","key":"10.1016\/j.lungcan.2015.08.012_bib0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1095-0397(00)00077-7","article-title":"11. evaluation of patients with known mesothelioma with 18F-fluorodeoxyglucose and PET. Comparison with computed tomography","volume":"3","author":"Zubeldia","year":"2000","journal-title":"Clin. Positron. Imaging"},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0205","first-page":"111","article-title":"Additional value of hybrid PET\/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma","volume":"8","author":"Ambrosini","year":"2005","journal-title":"Nucl. Med. Rev. Cent. East Eur."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00005382-200605000-00006","article-title":"Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging","volume":"21","author":"Truong","year":"2006","journal-title":"J. Thorac. Imaging"},{"issue":"6","key":"10.1016\/j.lungcan.2015.08.012_bib0215","first-page":"239","article-title":"Integrated FDG. PET-CT imaging improves staging in malignant pleural mesothelioma","volume":"46","author":"Kruger","year":"2007","journal-title":"Nuklearmedizin"},{"issue":"1\u20132","key":"10.1016\/j.lungcan.2015.08.012_bib0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2152\/jmi.56.16","article-title":"Is FDG-PET\/CT useful for managing malignant pleural mesothelioma?","volume":"56","author":"Otsuka","year":"2009","journal-title":"J. Med. Invest."},{"issue":"5","key":"10.1016\/j.lungcan.2015.08.012_bib0225","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00259-010-1704-x","article-title":"FDG PET\/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival","volume":"38","author":"Gerbaudo","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"6","key":"10.1016\/j.lungcan.2015.08.012_bib0230","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinimag.2013.06.009","article-title":"18F-FDG PET\/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up)","volume":"37","author":"Niccoli-Asabella","year":"2013","journal-title":"Clin. Imaging"},{"issue":"3","key":"10.1016\/j.lungcan.2015.08.012_bib0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11748-013-0345-y","article-title":"FDG PET\/CT is useful for detecting infiltration to the port site in patients with malignant pleural mesothelioma","volume":"62","author":"Kawaguchi","year":"2014","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2015.08.012_bib0240","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1754-9485.2011.02274.x","article-title":"Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET\/CT scan correlation","volume":"55","author":"Feigen","year":"2011","journal-title":"J. Med. Imaging Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2015.08.012_bib0245","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00066-011-2234-6","article-title":"PET-guided dose escalation tomotherapy in malignant pleural mesothelioma","volume":"187","author":"Fodor","year":"2011","journal-title":"Strahlenther Onkol."},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2015.08.012_bib0250","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2015.08.012_bib0255","first-page":"1241","article-title":"Prognostic value of FDG PET imaging in malignant pleural mesothelioma","volume":"40","author":"Benard","year":"1999","journal-title":"J. Nucl. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.lungcan.2015.08.012_bib0260","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.lungcan.2005.03.007","article-title":"The role of PET in the surgical management of malignant pleural mesothelioma","volume":"49","author":"Flores","year":"2005","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2015.08.012_bib0265","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/JTO.0b013e3182519d96","article-title":"High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology","volume":"7","author":"Kadota","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2015.08.012_bib0270","first-page":"1233","article-title":"Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma","volume":"17","author":"Abakay","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.lungcan.2015.08.012_bib0275","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1158\/1078-0432.CCR-09-2313","article-title":"A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters","volume":"16","author":"Nowak","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.lungcan.2015.08.012_bib0280","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11307-010-0426-6","article-title":"Current evidence base of FDG-PET\/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment","volume":"13","author":"Basu","year":"2011","journal-title":"Mol. Imaging Biol."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0285","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00259-013-2561-1","article-title":"The association of 18F-FDG PET\/CT parameters with survival in malignant pleural mesothelioma","volume":"41","author":"Klabatsa","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"10","key":"10.1016\/j.lungcan.2015.08.012_bib0290","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-010-1107-z","article-title":"Volume-based parameter of 18)F-FDG PET\/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications","volume":"17","author":"Lee","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2015.08.012_bib0295","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ejrad.2010.11.006","article-title":"Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET\/CT","volume":"81","author":"Schaefer","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.lungcan.2015.08.012_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7150\/jca.2586","article-title":"FDG PET\/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy","volume":"3","author":"Genestreti","year":"2012","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2015.08.012_bib0305","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2214\/AJR.06.1403","article-title":"Diffusion-weighted MRI in the body: applications and challenges in oncology","volume":"188","author":"Koh","year":"2007","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.lungcan.2015.08.012_bib0310","first-page":"132111","article-title":"Malignant pleural mesothelioma: visual assessment by using pleural pointillism at diffusion-weighted MR imaging","author":"Coolen","year":"2014","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0315","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1148\/radiol.2432060131","article-title":"Lung carcinoma: diffusion-weighted MR imaging\u2014preliminary evaluation with apparent diffusion coefficient 1","volume":"243","author":"Matoba","year":"2007","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.lungcan.2015.08.012_bib0320","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1148\/rg.316115515","article-title":"Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up","volume":"31","author":"Malayeri","year":"2011","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.lungcan.2015.08.012_bib0325","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3348\/kjr.2012.13.4.371","article-title":"Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts","volume":"13","author":"Kang","year":"2012","journal-title":"Korean J. Radiol."},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0330","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1148\/radiol.13130819","article-title":"Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients","volume":"270","author":"Donati","year":"2014","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.lungcan.2015.08.012_bib0335","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1007\/s00330-009-1469-4","article-title":"Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial","volume":"19","author":"Koh","year":"2009","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.lungcan.2015.08.012_bib0340","first-page":"181","article-title":"Image-based evaluation of tumor response to treatment: where is radiology today","volume":"30","author":"Kharuzhyk","year":"2008","journal-title":"Exp. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2015.08.012_bib0345","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejrad.2010.05.005","article-title":"Diffusion and perfusion MRI of the lung and mediastinum","volume":"76","author":"Henzler","year":"2010","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.lungcan.2015.08.012_bib0350","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1102\/1470-7330.2012.0041","article-title":"Diffusion magnetic resonance imaging of chest tumors","volume":"12","author":"Razek","year":"2011","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.lungcan.2015.08.012_bib0355","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1148\/radiol.12110872","article-title":"Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced mr imaging\u2014initial experience","volume":"263","author":"Coolen","year":"2012","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.lungcan.2015.08.012_bib0360","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.lungcan.2013.08.005","article-title":"Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group","volume":"82","author":"Armato","year":"2013","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2015.08.012_bib0365","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1378\/chest.129.6.1570","article-title":"Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a feasibility study of noninvasive assessment, therapeutic follow-up, and possible predictor of improved outcome","volume":"129","author":"Giesel","year":"2006","journal-title":"CHEST J."},{"issue":"20","key":"10.1016\/j.lungcan.2015.08.012_bib0370","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.2006.06.8080","article-title":"Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker","volume":"24","author":"Hylton","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2015.08.012_bib0375","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.acra.2007.12.014","article-title":"Pharmacokinetic analysis of malignant pleural mesothelioma-initial results of tumor microcirculation and its correlation to microvessel density (CD-34)","volume":"15","author":"Giesel","year":"2008","journal-title":"Acad. Radiol."},{"issue":"4","key":"10.1016\/j.lungcan.2015.08.012_bib0380","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacr.2014.12.003","article-title":"Role of the quantitative imaging biomarker alliance in optimizing ct for the evaluation of lung cancer screen\u2013detected nodules","volume":"12","author":"Mulshine","year":"2015","journal-title":"J. Am. Coll. Radiol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500215300362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T18:35:50Z","timestamp":1567103750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500215300362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0169500215300362"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.08.012","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response evaluation in mesothelioma: Beyond RECIST","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2015.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}